Saturday 17 October 2026
Export OPCH’s income statement to Excel — free account
Option Care Health, Inc.
OPCH Healthcare Medical Care Facilities
In the quarter to June 2026, revenue grew 1.86%, EPS grew 12.9%, free cash flow grew 112.4% and total debt rose 4.38%, each against the same quarter a year earlier. Revenue growth for five consecutive years; insiders bought in the last twelve months.
31.20
0.02
−0.06%
Follow OPCH
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
15.77 | 20.87 | 24.89 | 21.86 |
+8 more quarters Free account |
P/S ratio |
0.56 | 0.74 | 0.91 | 0.81 | |
P/FCF ratio |
10.55 | 19.84 | 23.78 | 20.36 | |
P/Operating CF |
17.47 | (348.23) | 143.89 | 32.22 | |
P/B ratio |
2.55 | 3.12 | 3.89 | 3.31 | |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Sales |
0.73 | 0.92 | 1.08 | 0.97 | |
EV/EBITDA |
10.22 | 12.84 | 14.76 | 13.17 | |
EV/Operating CF |
12.03 | 20.51 | 23.57 | 20.66 | |
EV/FCF |
13.73 | 24.46 | 28.06 | 24.22 | |
Quick Ratio |
0.86 | 0.95 | 0.85 | 0.95 | |
Current Ratio |
1.47 | 1.64 | 1.53 | 1.56 | |
Net Debt/EBITDA |
9.26 | 11.05 | 8.25 | 8.30 | |
Debt/Assets |
34.30% | 34.31% | 33.59% | 33.39% | |
Debt/Equity |
0.92 | 0.86 | 0.88 | 0.86 | |
Asset Turnover |
1.68 | 1.69 | 1.64 | 1.60 | |
Operating CF/Net income |
3.41 | (0.27) | 0.61 | 2.69 | |
Capex/Depreciation |
(0.58) | (0.55) | (0.65) | (0.51) | |
Interest Coverage |
6.07 | 5.45 | 7.19 | 5.97 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
11.42% | 12.92% | 11.75% | 11.99% | |
Intangible Assets out of Total Assets |
0.48 | 0.48 | 0.47 | 0.47 | |
Share Based Compensation of Revenue |
0.58% | 0.76% | 0.64% | 0.78% | |
Graham Net Nets |
(0.29) | (0.20) | (0.17) | (0.19) | |
Graham Number |
15.70 | 15.82 | 15.35 | 15.49 | |
Earnings Yield |
6.34% | 4.79% | 4.02% | 4.57% | |
Free Cash Flow Yield |
9.47% | 5.04% | 4.20% | 4.91% | |
Revenue per Share |
9.43 | 8.62 | 9.04 | 8.87 | |
Operating CF per Share |
1.20 | (0.08) | 0.22 | 0.86 | |
Capex per Share |
(0.07) | (0.06) | (0.08) | (0.06) | |
Free Cash Flow per Share |
1.13 | (0.14) | 0.14 | 0.80 | |
Cash per Share |
1.27 | 1.13 | 1.44 | 1.91 | |
Shareholders Equity per Share |
8.24 | 8.62 | 8.18 | 8.40 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
8.24 | 8.62 | 8.18 | 8.40 | |
Free Cash Flow |
172.52 | (21.16) | 22.25 | 130.24 | |
Working Capital |
381.12 | 465.36 | 435.62 | 458.86 | |
Capital Expenditures |
(11.08) | (9.05) | (13.65) | (9.19) | |
Net Current Asset Value |
(918.29) | (833.92) | (864.41) | (838.42) | |
EV/EBIT |
12.50 | 15.70 | 18.03 | 16.03 | |
Capex to Sales |
0.01 | 0.01 | 0.01 | 0.01 | |
Price to Operating Income |
9.61 | 12.73 | 15.28 | 13.47 | |
| Other line items | |||||
Average Receivables |
496.38 | 496.54 | 441.65 | 451.73 | |
Average Payables |
614.99 | 536.93 | 625.30 | 609.92 | |
Average Inventory |
401.57 | 392.36 | 429.64 | 363.16 | |
Average Assets |
3,380.80 | 3,344.31 | 3,438.76 | 3,453.79 | |
Average Common Equity |
1,309.92 | 1,350.95 | 1,365.32 | 1,392.45 |
Columns are period end dates